Farther Finance Advisors, LLC Ocugen, Inc. Transaction History

Farther Finance Advisors, LLC

  • $2.67 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024
BUY
$1.18 - $1.98 $62 - $104
53 New
53 $86,000
Q1 2024

May 13, 2024
SELL
$0.5 - $1.83 $250 - $915
-500 Closed
0 $0
Q1 2023

May 13, 2024
BUY
$0.82 - $1.33 $410 - $665
500 New
500 $427,000
Q1 2023

Sep 12, 2023
BUY
$0.82 - $1.33 $410 - $665
500 New
500 $427,000

Others Institutions Holding OCGN

# of Institutions
128
Shares Held
79.5M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $158M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email